These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 456935)

  • 21. [Estrogen receptors in the normal and pathological uterine tissue of women].
    Sturchak SV; Kokolina VF; Nikolaeva EI; Fanchenko ND
    Akush Ginekol (Mosk); 1976 Jul; (7):10-2. PubMed ID: 1020782
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of estrogens in the etiopathogenesis of endometrial adenocarcinoma].
    Campagnoli C; Chiara G; Gilli V
    Minerva Med; 1979 Jan; 70(2):97-111. PubMed ID: 219394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous estrogens and endometrial cancer.
    Gordan GS; Greenberg BG
    Postgrad Med; 1976 Jun; 59(6):66-77. PubMed ID: 778818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen use - risk of endometrial carcinoma.
    Hoogerland DL; Buchler DA; Crowley JJ; Carr WF
    Gynecol Oncol; 1978 Oct; 6(5):451-8. PubMed ID: 738623
    [No Abstract]   [Full Text] [Related]  

  • 25. The aetiology and pathology of endometrial cancer.
    Fox H
    Clin Obstet Gynaecol; 1976 Aug; 3(2):371-87. PubMed ID: 1009726
    [No Abstract]   [Full Text] [Related]  

  • 26. Clear cell adenocarcinoma of the uterus--ultrastructural and hormonal study.
    Horie A; Yasumoto K; Ueda H; Watanabe Y; Kotoo Y; Kurita Y
    Acta Pathol Jpn; 1977 Nov; 27(6):907-15. PubMed ID: 605800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The uptake of oestrogen by endometrial carcinoma.
    Taylor RW; Brush MG; King RJ; Witt M
    Proc R Soc Med; 1971 Apr; 64(4):407-8. PubMed ID: 4325267
    [No Abstract]   [Full Text] [Related]  

  • 28. [Risk factors in the onset of endometrial carcinoma].
    Prokić N; Terzić B
    Med Pregl; 1983; 36(5-6):207-10. PubMed ID: 6633452
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: correlations with stage and other clinicopathologic features.
    Nyholm HC; Nielsen AL; Lyndrup J; Norup P; Thorpe SM
    Am J Obstet Gynecol; 1992 Nov; 167(5):1334-42. PubMed ID: 1442987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues.
    Bergeron C; Ferenczy A; Shyamala G
    Lab Invest; 1988 Mar; 58(3):338-45. PubMed ID: 3347010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration.
    Jänne O; Kauppila A; Kontula K; Syrjälä P; Vihko R
    Int J Cancer; 1979 Nov; 24(5):545-54. PubMed ID: 231013
    [No Abstract]   [Full Text] [Related]  

  • 32. A predictable case of endometrial carcinoma.
    Coltart TM; Scott DJ; Turner DR; Vale J
    Guys Hosp Rep; 1972; 121(4):333-42. PubMed ID: 4668420
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of estrogen receptor levels in endometrial cancer cells.
    Gurpide E; Blumenthal R; Fleming H
    Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
    Itoh E
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Estrogen and progesterone receptors in endometrial carcinoma following endometrial radiation therapy].
    Thurzó L; Falkay G; Sas M
    Orv Hetil; 1985 Jan; 126(3):137-9. PubMed ID: 4038551
    [No Abstract]   [Full Text] [Related]  

  • 36. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis.
    Newbold RR; Bullock BC; McLachlan JA
    Cancer Res; 1990 Dec; 50(23):7677-81. PubMed ID: 2174729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogens and pancreatic cancer: some recent aspects.
    Andrén-Sandberg A
    Scand J Gastroenterol; 1986 Mar; 21(2):129-33. PubMed ID: 3520793
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of protein expression in endometrial adenocarcinoma cells by in vitro exposure to estradiol and progesterone.
    O'Brien TJ; Hernandez W; Jernstrom PJ; Seymour DB; Morrow CP; Sykes JA
    Am J Obstet Gynecol; 1981 Jan; 139(1):67-72. PubMed ID: 7457524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
    Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
    Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ENDOMETRIAL CARCINOMA--ENDOCRINOLOGICAL AND CLINICAL STUDIES.
    CHARLES D; BELL ET; LORAINE JA; HARKNESS RA
    Am J Obstet Gynecol; 1965 Apr; 91():1050-9. PubMed ID: 14280153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.